Mar Cuadrado‐Tejedor

Author

Also Known As

M Cuadrado-Tejedor, M. Cuadrado, M. Cuadrado Tejedor, M. Cuadrado-Tejedor, Mar Cuadrado, Mar Cuadrado-Tejedo, Mar Cuadrado-Tejedor, Mar Cuadrado‐Tejedor, Mark Bergholt Cuadrado

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Navarre Institute of Health Research Universitat de Barcelona Biomedical Research Networking Center on Neurodegenerative Diseases WuXi AppTec (China)

About

Mar Cuadrado‐Tejedor is an author at Universidad de Navarra specializing in medicine, neurodegenerative diseases, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	23	2.2K
2	Social Sciences	11	11	937
3	Engineering	2	2	35
4	Natural Sciences	2	2	128
5	Health Sciences	1	1	46

Mar Cuadrado‐Tejedor

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model Ana Ricobaraza, Mar Cuadrado‐Tejedor, Alberto Pérez‐Mediavilla, Neuropsychopharmacology Alzheimer's DiseaseAgingDementiaReduces Tau PathologyDisease Mouse Model	2009	409
Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease Ana Ricobaraza, Mar Cuadrado‐Tejedor, Sònia Marco, Hippocampus	2010	239
Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology Luís Escribano, Ana‐María Simón, Esther Gimeno, Neuropsychopharmacology Alzheimer's DiseaseTau PathologyDementiaMedicineDegenerative Pathology	2010	233
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease Mar Cuadrado‐Tejedor, Isabel Hervías, Ana Ricobaraza, British Journal of Pharmacology	2011	205
Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD Carolina García, Ana Ricobaraza, María Pascual‐Lucas, Neuropharmacology Neurodegenerative DiseasesAlzheimer's DiseaseBlood–brain BarrierNeurophysiologyMedicine	2012	184
Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice Elena M. Ribé, Mar Pérez, Berta Puig, Neurobiology of Disease Neurodegenerative DiseasesAlzheimer's DiseaseTransgenic Mouse ModelsAmyloid DepositionDegenerative Disease	2005	160
Insulin‐like growth factor 2 reverses memory and synaptic deficits in <scp>APP</scp> transgenic mice María Pascual‐Lucas, Silvia Viana da Silva, Marianna Di Scala, EMBO Molecular Medicine Knockout MouseSynaptic PlasticityNeurodegenerative DiseasesSignal TransductionMolecular Neuroscience	2014	139
Enhanced Expression of the Voltage-Dependent Anion Channel 1 (VDAC1) in Alzheimer's Disease Transgenic Mice: An Insight into the Pathogenic Effects of Amyloid-β Mar Cuadrado‐Tejedor, Marcos Vilariño, Felipe Cabodevilla, Journal of Alzheimer s Disease Synaptic TransmissionNeurochemical BiomarkersVdac1 ExpressionSynaptic SignalingSocial Sciences	2011	136
Early Changes in Hippocampal Eph Receptors Precede the Onset of Memory Decline in Mouse Models of Alzheimer's Disease Ana María Simón, Rakel López de Maturana, Ana Ricobaraza, Journal of Alzheimer s Disease	2009	112
Decreased levels of guanosine 3′, 5′‐monophosphate (c<scp>GMP</scp>) in cerebrospinal fluid (<scp>CSF</scp>) are associated with cognitive decline and amyloid pathology in <scp>A</scp>lzheimer's disease Ana Ugarte, Francisco J. Gil‐Bea, Carolina García, Neuropathology and Applied Neurobiology	2014	107

Page 1